Neil J. Shah, Manojkumar Bupathi, Rana R. McKay, Benjamin Garmezy, Joel Picus, Moshe C. Ornstein, Robert A. Figlin, Elaine T. Lam, Edward Paul Gelmann, Hans J. Hammers, Brian H. Rank, Song Zhao, Pedro C. Barata, Mohamad Adham Salkeni, Yusra F. Shao, Scott S. Tykodi, Thomas E. Hutson, Michael Jon Chisamore, Jose Luis Iglesias, Robert J. Motzer. "A phase 1b, open-label, safety, tolerability, and efficacy study of HC-7366 in combination with belzutifan in patients with advanced or metastatic renal cell carcinoma (NCT06234605).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps4614